Ionis Pharmaceuticals Stock In The News

IONS Stock  USD 43.35  1.31  2.93%   
The overall news coverage of Ionis Pharmaceuticals from major news outlets shows bullish sentiment on 14 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Ionis Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Ionis Pharmaceuticals. The specific impact of Ionis Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ionis Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ionis Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ionis Pharmaceuticals Backtesting and Ionis Pharmaceuticals Hype Analysis.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

Ionis Pharmaceuticals Today Top News and Investor Outlook

Yahoo News
New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding
https://finance.yahoo.com/m/12d771e8-d9d4-30a4-83ab-ff4ebd79e7bf/new-blood-thinners-will.html
 Bullish
Yahoo News
30 Biggest Biotechnology Companies in the World
https://finance.yahoo.com/news/30-biggest-biotechnology-companies-world-125016443.html
 Bullish
Yahoo News
Ionis to present at upcoming investor conferences
https://finance.yahoo.com/news/ionis-present-upcoming-investor-conferences-120500259.html
 Bullish
Yahoo News
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
https://finance.yahoo.com/news/ionis-pharmaceuticals-inc-nasdaq-ions-130040275.html
 Neutral
Yahoo News
Ionis Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
https://finance.yahoo.com/news/ionis-pharmaceuticals-full-2023-earnings-103631348.html
 Neutral
Yahoo News
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/ionis-pharmaceuticals-inc-nasdaq-ions-155934881.html
 Bullish
Yahoo News
Ionis (IONS) Q4 Loss Narrower Than Expected, Sales Surge Y/Y
https://finance.yahoo.com/news/ionis-ions-q4-loss-narrower-152900822.html
 Bullish
Yahoo News
Q4 2023 Ionis Pharmaceuticals Inc Earnings Call
https://finance.yahoo.com/news/q4-2023-ionis-pharmaceuticals-inc-072010893.html
 Bullish
Yahoo News
Ionis Pharmaceuticals Inc (IONS) Surpasses Revenue Guidance for 2023, Sets Sights on 2024 Growth
https://finance.yahoo.com/news/ionis-pharmaceuticals-inc-ions-surpasses-163148096.html
 Bullish
Yahoo News
Ionis Pharmaceuticals (IONS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://finance.yahoo.com/news/ionis-pharmaceuticals-ions-q4-earnings-143009718.html
 Bullish

Ionis Pharmaceuticals Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ionis and other traded companies coverage. We help investors stay connected with Ionis headlines for the 29th of March to make an informed investment decision based on correlating the impacts of news items on Ionis Stock performance. Please note that trading solely based on the Ionis Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ionis Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ionis Pharmaceuticals investors visualize upcoming and past events in order to time the market based on Ionis Pharmaceuticals noise-free hype analysis.
Ionis Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ionis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ionis Pharmaceuticals that are available to investors today. That information is available publicly through Ionis media outlets and privately through word of mouth or via Ionis internal channels. However, regardless of the origin, that massive amount of Ionis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ionis Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ionis Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ionis Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ionis Pharmaceuticals alpha.

Ionis Largest EPS Surprises

Earnings surprises can significantly impact Ionis Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-02-27
2017-12-310.010.020.01100 
2013-05-07
2013-03-31-0.02-0.03-0.0150 
2009-08-06
2009-06-30-0.02-0.03-0.0150 
2018-05-04
2018-03-31-0.03-0.010.0266 
2017-05-09
2017-03-310.050.03-0.0240 
2016-11-09
2016-09-300.080.06-0.0225 
View All Earnings Estimates

Ionis Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ionis Pharmaceuticals Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
25th of March 2024
Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 20...
at finance.yahoo.com 
Macroaxis News
20th of March 2024
Acquisition by Schneider Eugene of 20400 shares of Ionis Pharmaceuticals subject to Rule 1...
at MacroaxisInsider 
zacks News
14th of March 2024
Ionis Drug Meets Mid-Stage MASH Study Goals
at zacks.com 
Yahoo News
13th of March 2024
UPDATE 1-Ionis Pharmas fatty liver disease drug succeeds in mid-stage trial
at finance.yahoo.com 
news
12th of March 2024
Jacobs Levy Equity Management Inc. Sells 176,441 Shares of Ionis Pharmaceuticals, Inc.
at thelincolnianonline.com 
Google News at Macroaxis
7th of March 2024
Envestnet Asset Management Inc. Increases Stock Position in Ionis Pharmaceuticals, Inc. - ...
at news.google.com 
benzinga news
6th of March 2024
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA in In...
at benzinga.com 
insidermonkey News
22nd of February 2024
Ionis Pharmaceuticals, Inc. Q4 2023 Earnings Call Transcript
at insidermonkey.com 
zacks News
15th of February 2024
Ionis Pharmaceuticals Q4 Earnings Preview What You Should Know Beyond the Headline Estimat...
at zacks.com 
businesswire News
30th of January 2024
Vect-Horus signe un accord exclusif de licence avec Ionis Pharmaceuticals pour promouvoir ...
at businesswire.com 

Ionis Pharmaceuticals Investors Sentiment

The influence of Ionis Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ionis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ionis Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ionis. The trend in average sentiment can be used to explain how an investor holding Ionis can time the market purely based on public headlines and social activities around Ionis Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ionis Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ionis Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ionis Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ionis Pharmaceuticals.

Ionis Pharmaceuticals Implied Volatility

    
  35.37  
Ionis Pharmaceuticals' implied volatility exposes the market's sentiment of Ionis Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ionis Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ionis Pharmaceuticals stock will not fluctuate a lot when Ionis Pharmaceuticals' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ionis Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ionis Pharmaceuticals' short interest history, or implied volatility extrapolated from Ionis Pharmaceuticals options trading.
When determining whether Ionis Pharmaceuticals is a strong investment it is important to analyze Ionis Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ionis Pharmaceuticals' future performance. For an informed investment choice regarding Ionis Stock, refer to the following important reports:
Check out Ionis Pharmaceuticals Backtesting and Ionis Pharmaceuticals Hype Analysis.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Ionis Stock analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Ionis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ionis Pharmaceuticals. If investors know Ionis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ionis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.44)
Earnings Share
(2.56)
Revenue Per Share
5.501
Quarterly Revenue Growth
1.136
Return On Assets
(0.08)
The market value of Ionis Pharmaceuticals is measured differently than its book value, which is the value of Ionis that is recorded on the company's balance sheet. Investors also form their own opinion of Ionis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ionis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ionis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ionis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ionis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ionis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ionis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.